COVID‐19 in DMARD‐treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database

BACKGROUND: To determine whether the use of disease‐modifying antirheumatic drugs (DMARDs) is linked to the risk of COVID‐19 among patients with inflammatory rheumatic diseases (IRDs). METHODS: We performed a disproportionality analysis of the World Health Organization pharmacovigilance database bet...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Fundam Clin Pharmacol
Glavni autori: Dernoncourt, Amandine, Schmidt, Jean, Duhaut, Pierre, Liabeuf, Sophie, Gras‐Champel, Valérie, Masmoudi, Kamel, Bennis, Youssef, Batteux, Benjamin
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2021
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239613/
https://ncbi.nlm.nih.gov/pubmed/33973280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/fcp.12695
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items